Albireo Pharma, Inc.
ALBO · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$34 | -$108 | -$63 | -$46 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | -$93 | -$15 | $4 | $5 |
| Stock-Based Comp. | $16 | $15 | $8 | $6 |
| Change in WC | -$10 | -$5 | -$10 | $2 |
| Other Non-Cash | $13 | $11 | $8 | $7 |
| Operating Cash Flow | -$108 | -$101 | -$53 | -$27 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $103 | $0 | $0 | $0 |
| Investing Cash Flow | $103 | -$0 | -$1 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $193 | $21 | $94 |
| Stock Repurch. | -$0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $3 | $220 | $24 | $139 |
| Financing Cash Flow | $3 | $220 | $24 | $139 |
| Forex Effect | -$1 | $0 | -$2 | -$2 |
| Net Chg. in Cash | -$3 | $119 | -$32 | $111 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $251 | $132 | $164 | $53 |
| End Cash | $248 | $251 | $132 | $164 |
| Free Cash Flow | -$108 | -$101 | -$53 | -$27 |